Rinhepa 25000IU Injection
Marketer
United Biotech Pvt Ltd
Salt Composition
Heparin (25000IU)
Overview Rinhepa 25000IU Injection
Heparin 25000IU Injection acts as a blood thinner, preventing the development and expansion of potentially dangerous blood clots within the circulatory system, including the legs, lungs, and heart. Administration is strictly under medical guidance; dosage frequency is determined by your physician and may be adjusted based on treatment efficacy. Consistent use, even in the absence of symptoms, is crucial for ongoing protection. Regular blood tests will monitor treatment effectiveness, potassium levels, and platelet count. Increased bleeding risk is a potential side effect; promptly report any signs of unusual bleeding (e.g., petechiae, hematuria, melena) to your doctor. Exercise caution with activities that may cause injury (e.g., shaving, contact sports). Prior to initiating treatment, disclose all existing medical conditions and medications to your physician. Pregnant individuals should consult their doctor regarding the safety of this medication.
Uses of Rinhepa 25000IU Injection
Thrombosis prophylaxis
Major Benefits of Rinhepa 25000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rinhepa 25000IU Injection:
- Bleeding
- Erythema (skin redness)
How to use Rinhepa 25000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Rinhepa 25000IU Injection works:
Heparin 25000IU Injection acts as a blood thinner, inhibiting the development of dangerous blood clots. While it doesn't break down pre-existing clots, it effectively stops their expansion, thus averting vascular obstructions.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rinhepa 25000IU Injection and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Rinhepa 25000IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
During breastfeeding, Rinhepa 25000IU Injection is considered safe. Research in humans indicates negligible transfer into breast milk, posing no apparent risk to the infant. The minimal quantities of Rinhepa 25000IU Injection detected in breast milk result in insignificant exposure to the baby, precluding any anticipated adverse effects.
DrivingSAFE
Driving ability is typically unaffected by Rinhepa 25000IU Injection.
KidneySAFE IF PRESCRIBED
The administration of Rinhepa 25000IU Injection is considered safe for individuals with renal impairment; no dosage modification is necessary. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Rinhepa 25000IU Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Rinhepa 25000IU Injection :
Should you inadvertently skip a dose of Rinhepa 25000IU Injection, seek medical advice.
Facts to Know About Rinhepa 25000IU Injection
| Label | Value |
|---|---|
| Chemical Type | Glycosaminoglycan Sulfate |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Actions | Unfractionated Heparin |
3,018 People bought this recently